Taherkhani Sakineh
School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Int J Reprod Biomed. 2023 Apr 14;21(3):193-204. doi: 10.18502/ijrm.v21i3.13195. eCollection 2023 Mar.
The decision to use a living or deceased donor to perform uterus transplantation (UTx) is an evaluation of benefit and harm and is based on the medical team's choices. The current study determines the differences between living and deceased donation in human UTx according to determinant factors in choosing the donor type. For this review study, the PubMed database was searched without time, language, and location limitations up to May 2022. From 113 identified articles, 45 papers were included in the study for review. According to the results, in comparison to living donation, the biggest advantage of deceased donation is the lack of surgical and or psychological risks for the donor. In contrast, a comprehensive pre-transplantation medical assessment is less possible in deceased donation, and preplanned surgery cannot be realized. According to published peer-reviewed clinical trials on UTx, the graft failure rates in living and deceased donor UTx are 21% and 36%, respectively. Supposing all recipients who did not have graft failure underwent embryo transfer, live birth rates in living and deceased donor UTx procedures are almost 63% and 71%, respectively. Currently, considering the occurrence of live births from both donations, particularly from nulliparous deceased donor, increased demand for UTx in the near future, shortage of uterus grafts, and lack of sufficient data for a comprehensive comparison between the 2 types of donation, the use of both donations still seems necessary and rational.
决定使用活体或已故供体进行子宫移植(UTx)是对利弊的评估,且基于医疗团队的选择。本研究根据选择供体类型的决定因素,确定人类子宫移植中活体捐赠和已故捐赠之间的差异。对于这项综述研究,截至2022年5月,对PubMed数据库进行了无时间、语言和位置限制的检索。从113篇已识别的文章中,纳入45篇论文进行研究综述。结果显示,与活体捐赠相比,已故捐赠的最大优势在于供体不存在手术和/或心理风险。相比之下,已故捐赠中进行全面的移植前医学评估不太可能,且无法实现预先计划的手术。根据已发表的关于子宫移植的同行评审临床试验,活体供体子宫移植和已故供体子宫移植的移植物失败率分别为21%和36%。假设所有未发生移植物失败的受者都接受了胚胎移植,活体供体子宫移植和已故供体子宫移植手术的活产率分别约为63%和71%。目前,考虑到两种捐赠方式都有活产情况发生,尤其是来自未生育已故供体的情况,近期子宫移植需求增加,子宫移植物短缺,且缺乏足够数据对两种捐赠类型进行全面比较,两种捐赠方式的使用似乎仍然必要且合理。